P/E ratio for Horizon Therapeutics (HZNP)

P/E ratio history for Horizon Therapeutics from 2011 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Amgen AMGN	20.5	-66.18%	🇺🇸 USA
AstraZeneca AZN	32.4	-46.56%	🇬🇧 UK
Pfizer PFE	13.5	-77.69%	🇺🇸 USA
Dr. Reddy's RDY	3.77	-93.78%	🇮🇳 India
Merck MRK	54.8	-9.50%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.